Meta-analysis of 74,046 individuals identifies 11 new susceptibility loci for Alzheimer's disease
2013 · Nature Genetics · 4,538 citations
https://doi.org/10.1038/ng.2802
B
Benjamin Grenier‐Boley
Inserm(FR)
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
131
Papers
20.3K
Citations
41
h-index
66
i10-index
Benjamin Grenier‐Boley is an academic researcher from Inserm. The author has contributed to research in topics: Alzheimer's disease research and treatments & Genetic Associations and Epidemiology & Bioinformatics and Genomic Networks. The author has an h-index of 41, co-authored 112 publications.
ORCID: 0009-0004-3412-3997Papers by this author
worksGenetic meta-analysis of diagnosed Alzheimer’s disease identifies new risk loci and implicates Aβ, tau, immunity and lipid processing
2019 · Nature Genetics · 3,124 citations
https://doi.org/10.1038/s41588-019-0358-2
New insights into the genetic etiology of Alzheimer’s disease and related dementias
2022 · Nature Genetics · 2,354 citations
https://doi.org/10.1038/s41588-022-01024-z
Analysis of shared heritability in common disorders of the brain
2018 · Science · 1,991 citations
https://doi.org/10.1126/science.aap8757
Gene-Wide Analysis Detects Two New Susceptibility Genes for Alzheimer's Disease
2014 · PLoS ONE · 1,405 citations
https://doi.org/10.1371/journal.pone.0094661
Rare coding variants in PLCG2, ABI3, and TREM2 implicate microglial-mediated innate immunity in Alzheimer's disease
2017 · Nature Genetics · 1,083 citations
https://doi.org/10.1038/ng.3916
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat